Skip to main content

Table 1 Summary of the clinical pathological status of triple-negative cases (TNBC) and non triple-negative cases (non-TNBC)

From: Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women

Characteristic

 

No. of patients (%)

 

TNBC (N = 42)

non-TNBC (N =298)

TOTAL

AGE AT DIAGNOSIS (y)

  ≤ 40

15 (35.7%)

49 (16.4%)

64 (18.8%)

  41 ≤ y ≤ 49

13 (31.0%)

113 (37.9%)

126 (37.1%)

  50 ≤ y ≤ 65

13 (31.0%)

107 (35.9%)

120 (35.3%)

  > 65

1 (2.4%)

29 (9.7%)

30 (8.8%)

HISTOLOGY

  DCIS

3 (7.1%)

35 (11.7%)

38 (11.2%)

  IDC

35 (83.3%)

232 (77.9%)

267 (78.5%)

  Others

4 (9.5%)

31 (10.4%)

35 (10.3%)

GRADE

  1 (well differentiated)

0 (0.0%)

 7 (2.3%)

 7 (2.1%)

  2 (moderately differentiated)

6 (14.3%)

110 (36.9%)

116 (34.1%)

  3 (poorly differentiated)

32 (76.2%)

151 (50.7%)

183 (53.8%)

  Not determined

4 (9.5%)

30 (10.1%)

34 (10.0%)

TUMOR SIZE (cm)

  ≤ 2

12 (28.6%)

109 (36.6%)

121 (35.6%)

  2 < cm ≤ 5

15 (35.7%)

99 (33.2%)

114 (33.5%)

  > 5

3 (7.1%)

15 (5.0%)

18 (5.3%)

  Not determined

12 (28.6%)

75 (25.2%)

87 (25.6%)

LYMPH NODE INFILTRATION

  Positive

17 (40.5%)

91 (30.5%)

108 (31.8%)

  Negative

25 (59.5%)

194 (65.1%)

219 (64.4%)

  Not determined

0 (0.0%)

13 (4.4%)

13 (3.8%)

p53 STATUS

  Positive

15 (35.7%)

45 (15.1%)

60 (17.6%)

  Negative

27 (64.3%)

251 (84.2%)

278 (81.8%)

  Not determined

0 (0.0%)

 2 (0.7%)

 2 (0.6%)

  1. Note: Percentage (%) indicates the percentage within the subgroup. DCIS ductal carcinoma in-situ, IDC invasive ductal carcinoma.